It Beat, It Raised, And It Sold Off Anyway. Here Is What You Do With That

Institutions bought 37,301 calls on this off-price retailer Tuesday, the company beat plan on Wednesday morning, and the shares closed down 4.2% anyway.

The flow read the quarter correctly and the market punished one cautious quarter of guidance instead, which leaves you buying a raised full-year outlook at a 15% discount to the highs.

Income Stocks (Sponsored)

7 “Forever” Dividend Stocks Revealed

No company increases its dividend for 50+ years without doing something right.

Companies don’t increase their dividend for 5 decades by chance.

It requires staying power, smart management — and a business designed to endure through uncertainty.

Inside our latest report, you’ll discover 7 “buy and hold forever” stocks with long-term payout streaks and exceptionally strong balance sheets.

One healthcare powerhouse has delivered 61 consecutive years of dividend increases.

These are the types of businesses engineered to quietly build lasting wealth over time.

Claim your free copy now.

(By clicking the link above, you agree to receive emails from Marketbeat. You can opt out at any time. - Privacy Policy)

The TJX Companies

August 20 – Pre‑market
Ticker: TJX | Sector: Consumer Cyclical (Off-Price Retail) | Market Cap: $155.42B

30‑Second Take

Why now? TJX reported second-quarter FY27 results before the bell on Wednesday and the quarter came in above plan. Net sales of $15.18 billion, up 5% from $14.40 billion. Comparable sales up 4%, and up 5% across the first half. Diluted EPS of $1.36, up 24% from $1.10 a year ago.

Strip out the $0.14 net benefit from tariff refunds, and adjusted EPS was $1.22, still up 11%. That is the number to anchor on.

Management then raised the full-year FY27 outlook: diluted EPS of $5.31 to $5.36, adjusted EPS of $5.15 to $5.20, and pretax margin of 12.3% to 12.4%.

The stock closed at $140.69, down 8.8% YTD. The reason is one line in the guide. Third-quarter adjusted EPS of $1.30 to $1.32 sits below the roughly $1.35 the Street was carrying, with comps planned up 2% to 3%.

So the business beat on sales, margin, and earnings; the full year went up, and the share price went down on a single quarter of conservative guidance. The 37,301 call contracts bought Tuesday, 437% above the ~6,950 daily average, read the quarter right.

Trade Setup

Timeframe: 4 to 12 weeks
Edge type: Post-earnings dislocation + consumer trade-down

The setup changed shape the moment the print landed. You are no longer paying for an unknown quarter. You know comps ran 4%, you know the full-year guide went up, and you know the only soft spot is one quarter of EPS guidance from a management team with a long history of setting the bar low.

Dividend Yield Leaders (Sponsored)

7 High Yield Dividend Stocks to Buy Now

Love steady payouts?

This free report reveals 7 high-yield dividend stocks you need to know about.

From Company #3, a tobacco giant innovating with smokeless products, to Company #4, famously known as “The Monthly Dividend Company,” these picks deliver steady income you can count on.

Perfect for income-focused investors.

Download the Free Dividend Report Now

(By clicking this link you agree to receive emails from Trading Tips and our affiliates. You can opt out at any time. - Privacy Policy)

What's the single hardest part of your investment process?

Sizing — knowing how much to put into a high-conviction idea without overconcentrating

Patience — waiting for the right price without feeling like I'm missing the move

Selling — deciding when the thesis is broken vs. when the market is just being wrong

Ignoring noise — filtering out macro commentary and headlines that don't affect my thesis

Snapshot Table

Metric	Value	Current Stance
Price	$140.69	Post-earnings dip on a soft Q3 guide
52-Week Range	$134.75 - $170.00	Room to reclaim highs
Market Cap	~$155.42B	Large-cap, deep liquidity
P/E Ratio	26.02 (TTM)	Premium multiple for the group
Beta	0.62	Low volatility vs. Market
Avg Daily Volume	5,629,798	Deep, liquid name

Chart

1-Month Trading Summary: TJX has been under pressure for most of the past month, sliding roughly 7% over the 30-day period as retail wobbled on tariff and consumer-spending fears. Wednesday's 4.2% post-earnings drop to $144.50 added to it.

The stock now sits about 15% below its 52-week high of $170.00 and only about $10 above its 52-week low of $134.75.

That gap is your setup. You are buying a raised full-year forecast at a price that was set by one cautious quarter of guidance.

Bull Case

Core thesis: The consumer trade-down is real, and it just showed up in the numbers.

Target lifted its full-year guide this week, and TJX posted 4% comps on top of a 5% first half. Both point to a shopper who is still spending but hunting aggressively for value, and that is the exact tailwind TJX rides. When households pull back at the department stores, they trade down into T.J. Maxx, Marshalls, HomeGoods and Sierra. All four are TJX brands, and this pattern has held for 30 years.

Catalysts: Management raised full-year EPS and pretax margin guidance, and told the market it plans to accelerate store growth beginning in FY28. Companies do not add square footage into demand they do not believe in.

The structural story is intact too. TJX compounds revenue and earnings at high-single to low-double-digit rates, throws off serious cash, and keeps buying back its own stock.

What stands out most: this is a defensive growth name that just beat and raised, trading 15% off its high because one quarter of guidance came in $0.03 light.

Bear Case

Guidance risk is real, not imaginary. Q3 adjusted EPS of $1.30 to $1.32 against a ~$1.35 consensus tells you the back half is not going to be a straight line. If Q3 lands at the low end, you get another leg down, and the stock has already broken its uptrend. Size accordingly and do not put on more than you would be comfortable eating a 5% to 7% move on.

Quality of earnings deserves a look too. The headline $1.36 included a $0.14 net benefit from tariff refunds. That is not recurring. Underlying growth was 11%, which is good, not spectacular, and tariff policy can just as easily run the other way on a business that sources inventory internationally.

Third: valuation is not cheap. At $144.50 against TTM EPS of $5.14, you are paying about 28 times trailing earnings, and about 28 times the adjusted FY27 midpoint. You are buying a compounder at a compounder multiple, not a bargain.

Quick Checklist

✅ Q2 beat confirmed: sales $15.18B up 5%, comps up 4%, diluted EPS $1.36 up 24%
✅ Full-year FY27 guidance raised to $5.31 to $5.36 diluted ($5.15 to $5.20 adjusted)
⚠️ Q3 adjusted EPS guide of $1.30 to $1.32 sits under the ~$1.35 consensus
✅ Next catalyst dated: Q3 FY27 earnings on November 18, 2026

Deep‑Dive Links

That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned!

Best Regards,
—Noah Zelvis
Everyday Alpha

Everyday Alpha is a publication of Elite Trade Media LLC.

Disclosure: Content is for informational and entertainment purposes only and is not investment advice. Do not base investment decisions on this newsletter. Securities mentioned may be owned by our owners or operators, which could affect our objectivity. Consult a licensed financial advisor before making any investment decision. We may receive compensation from advertisers and affiliate links in this email, including for featured third-party offers.

Everyday Alpha and its parent company are not registered investment advisors, broker-dealers, or financial planners. Nothing published by Everyday Alpha — including but not limited to newsletters, emails, text messages, social media posts, or website content — constitutes personalized investment advice, a recommendation to buy or sell any security, or an offer or solicitation to purchase or sell any financial instrument.

All content is provided strictly for informational and educational purposes. You should not rely on any content published by Everyday Alpha as a substitute for professional financial, legal, or tax advice tailored to your individual circumstances. Always consult a qualified, licensed financial advisor before making any investment decision.

Forward-Looking Statements: Content may contain forward-looking statements, including projections, opinions, and expectations regarding future events or financial performance. These statements are based on current information and assumptions at the time of writing and are inherently uncertain. Actual results may differ materially. Everyday Alpha is under no obligation to update or revise any forward-looking statement after publication.

No Guarantee of Accuracy: While Everyday Alpha strives for accuracy, we make no representation or warranty — express or implied — regarding the completeness, reliability, or timeliness of any information provided. Errors, omissions, and outdated information may occur. All content is provided "as is" without warranty of any kind.

Past Performance: Any reference to past performance of a security, strategy, or index is not indicative of future results. All investments carry risk, including the potential loss of principal. You could lose some or all of your invested capital.

Editorial Process Disclosure: Everyday Alpha uses proprietary research tools, including AI, in its editorial process. All content is reviewed and approved by our editorial team before publication. Readers should independently verify any information before making financial decisions.

Advertising & Affiliate Disclosure: Everyday Alpha receives compensation from third-party advertisers and may include paid promotions, sponsored content, and affiliate links within its publications. When you click on certain links or sign up for third-party services featured in our content, we may receive a commission or flat fee. This compensation may influence which companies or products are covered and how they are presented, though it does not affect our editorial opinions. Sponsored content is provided by advertisers and does not represent the views of Everyday Alpha.

Conflicts of Interest: Contributors, editors, and affiliates of Everyday Alpha may hold positions in securities discussed in our content. These positions may be established or liquidated at any time without notice to readers.

Limitation of Liability: Under no circumstances shall Everyday Alpha, its owners, employees, affiliates, or contributors be liable for any direct, indirect, incidental, consequential, or punitive damages arising from your use of or reliance on any content published by Everyday Alpha.

By reading, subscribing to, or otherwise engaging with Everyday Alpha content, you acknowledge and agree to the terms above.

This email was sent via the beehiiv platform on behalf of Elite Trade Media LLC.

Update your email preferences or unsubscribe here

1032 E Brandon Blvd #9644
Brandon, FL 33511, United States

Sponsored Links